Akanda Corp. (AKAN)
NASDAQ: AKAN · Real-Time Price · USD
57.09
+8.13 (16.61%)
At close: May 1, 2026, 4:00 PM EDT
46.50
-10.59 (-18.55%)
After-hours: May 1, 2026, 7:59 PM EDT
Akanda Market Cap
Akanda has a market cap or net worth of $30.51 million as of May 1, 2026. Its market cap has increased by 1,096.95% in one year.
Market Cap
30.51M
Enterprise Value
28.38M
1-Year Change
1,096.95%
Ranking
Category
Stock Price
$57.09
Market Cap Chart
Since the IPO on March 15, 2022, Akanda's market cap has decreased from $302.99M to $30.51M, a decrease of -89.93%. That is a compound annual growth rate of -42.63%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 1, 2026 | 30.51M | 9,061.53% |
| Dec 31, 2025 | 333.02K | -85.41% |
| Dec 31, 2024 | 2.28M | 28.87% |
| Dec 29, 2023 | 1.77M | -63.24% |
| Dec 30, 2022 | 4.82M | -98.41% |
| Mar 15, 2022 | 302.99M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Incannex Healthcare | 65.26M |
| Cumberland Pharmaceuticals | 64.16M |
| BGM Group | 57.47M |
| Talphera | 46.19M |
| InterCure | 46.15M |
| Zhengye Biotechnology Holding | 43.60M |
| Rockwell Medical | 34.30M |
| BioXcel Therapeutics | 33.84M |